FDA Inspection
Centaur Pharmaceuticals Private Ltd.Centaur Pharmaceuticals Private Ltd. – FDA Inspection, Sep 27, 2019
Record Details
This FDA Inspection record concerns Centaur Pharmaceuticals Private Ltd., with an inspection on September 27, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dc970634-ace9-4877-84d2-d58de204ae0a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1107995
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Centaur Pharmaceuticals Private Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 25, 2025 | Not classified | Office of Inspections and Investigations | |
| November 21, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 13, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 11, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Centaur Pharmaceuticals Private Ltd.
- FDA Inspection 1281041 - 2025-07-25
- FDA Inspection 1192256 - 2022-11-21
- FDA Inspection 994501 - 2016-10-13
- FDA Inspection 914387 - 2015-02-05
- FDA Inspection 740701 - 2011-08-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.